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Figure 1: Lymphoid system 
This scheme represents the B and T cell differentiation in the bone marrow, thymus and 
spleen. The myeloid differentiation in the bone marrow is not illustrated in detail as it is not 
part of the lymphoid system. 
 
1.1.1 B cell development 
 
Bone marrow 
 
B lymphocytes arise from a common lymphoid progenitor (CLP) detectable early in 
embryonic development in the fetal liver and, during adulthood, in the bone marrow. 
These CLP then differentiate into Progenitor B cells (Pro B cells) which are 
characterized by surface expression of the CD45 phosphatase isoform B220 and to a 
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The activated B cells migrate towards the center of the secondary follicle, forming the 
germinal center (GC). The Germinal Center is reviewed in Hess et al., 1998, 
Tarlinton, 1998, and van Eijk et al., 2001. The proliferating activated B cells 
(centroblasts) then move to one edge of the follicle thus forming the dark zone where 
they perform somatic hypermutation and give rise to small centrocytes. Then they 
move into the light zone of the germinal center containing numerous follicular 
dendritic cells (FDC) which select high-affinity centrocytes by binding to antigen-
antibody complexes. Within the light zone the B cells perform class switching (see 
1.1.1.5) and differentiate into small memory B cells and large plasmablasts. The 
plasmablasts develop into long-lived plasma cells and begin to secrete antibodies 
(Fig. 2b). 
 
 
 
 
 
 
 
Figure 2: Spleen 
architecture. 
(A) Structure of the 
spleen. The blood born 
pathogens are filtrated 
in the Red Pulp so that 
the B cells in the PALS 
are activated and form 
primary and secondary 
follicles. (B) The 
structure of secondary 
follicles containing the 
Germinal Center is 
depicted. The activated 
B cells enter the Dark 
Zone of the GC and 
undergo affinity 
maturation. The 
Centrocytes that have a 
high affinity for the 
antigen survive and 
differentiate into Plasma 
cells and Memory B 
cells. PALS: 
Periarteriolar Lymphoid 
Sheath; IDC: 
Interdigitating Dendritic 
Cells; GC: Germinal 
Center; FDC: Follicular 
Dendritic Cells; MZ: 
Marginal Zone. 
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1.1.1.1 Heavy chain rearrangement 
 
An immunoglobulin molecule (antibody) is constituted of a pair of identical Ig heavy 
chains and a pair of identical Ig light chains. The N-terminal part of the heavy chain 
and the light chain has an amino acid sequence called variable region which is 
involved in specific antigen binding. The C-terminal part is more conserved and 
therefore is called the constant region. It prescribes the class and effector function of 
an antibody. The variable regions are assembled from germline V, D, J gene 
segments through a site-specific recombination reaction known as V(D)J 
recombination (Jung and Alt, 2004; Bassing et al., 2002). 
The murine IgH locus spans about 3 Mb (Jung et al., 2006). About 150 functional VH 
gene segments, each with their own promoter and leader sequence (for protein 
sorting), comprise 15 VH segment families upstream of 12-13 DH gene segments. 
Four JH gene segments are located downstream of the DH segments, and 8 constant 
region exons span about 200kb downstream of the JH segments (Fig. 3). The V(D)J  
 
Figure 3: Organization and control elements of the murine immunoglobulin heavy 
(IgH) gene locus (not drawn to scale). 
The variable (V), diversity (D), joining (J) and constant (C) gene segments are represented 
as boxes. The enhancers are shown in grey. Distances shown are from the murine 129 strain 
and vary between strains. 
 
recombination is generated by RAG mediated double strand breaks (DSBs) followed 
by religation at the borders between two coding segments and their flanking 
recombination signal sequences (RSS) bringing first the D and J regions, and then 
the V to DJ regions together. The RSS (nonamer-12/23bp-heptamer) are present 3’ 
of each V region, 5’ and 3’ of D regions and 5’ of each J region. The V-D-J order of 
recombination is ensured by the rule that a RSS with a 12 bp spacer can only join 
with a RSS with a 23 bp spacer (Fig. 4a). The V(D)J recombination results in placing 
the germline VH promoter in close proximity to a strong enhancer element (iEμ) that 
lies in the intron between the JH and Cμ exons (Fig. 4b). Furthermore there is a large 
enhancer region 3’ of Cα (3’ enhancer) which also regulate the expression of the IgH 
gene. By default, IgH polypeptide utilizes the μ constant regions or –in mature B 
cells- the Cδ region, which can replace Cμ by alternative splicing mechanism. The 
diversity of Ig genes during V(D)J recombination is increased by the terminal 
deoxynucleotidyl transferase (TdT), which randomly adds N-nucleotides at the 
rearrangement joints. After one allele is productively rearranged, the recombination 
machinery is quickly downregulated so that generally, in any one cell only one 
successfully rearranged IgH and IgL locus is found (allelic exclusion). In immature B 
cells the yield of unproductive rearrangement is increased by a mechanism called 
receptor editing, which drives further recombination of regions that lie outside of the 
already recombined regions. 
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Figure 4: Assembly and expression of IgH genes. 
(A) Variable (VH), diversity (DH), and joining (JH) gene segments are shown, along with their 
flanking recombination signal sequences (RSS). RS heptamers are depicted as yellow 
triangles, whereas RS nonamers are depicted as white triangles. Spacer lengths are 
indicated above the various RSS. (B) Location of the three complementarity determining 
(antigen contact) regions (CDRs) on the assembled VHDJH exon is shown. Transcription 
initiates upstream of the assembled VHDJH exon and proceeds through the four Cμ exons 
and the membrane (m) and secreted (s) exons. Possible splicing events are indicated. (from 
Jung et al., 2006) 
 
1.1.1.2 Light chain rearrangement 
 
The light chain is encoded by the κ and the λ loci that are alternatively used. The κ 
light chain locus lacks the D regions and there is only one C region. Enhancers are 
found on similar positions as the IgH gene. The λ light chain locus has multiple 
sequential pairs of J-C and has no intronic enhancer (Fig. 5). The recombination 
machinery is identical to the heavy chain, the κ light chain is generally rearranged 
first, and in case of unproductive rearrangement the λ light chain is used. 
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Figure 5: Organization and control elements of the murine immunoglobulin light chain 
(Igκ, Igλ) gene loci. 
The variable (V), joining (J) and constant (C) gene segments are represented as boxes. The 
enhancers are shown in grey. 
 
 
1.1.1.3 Immunoglobulin affinity maturation 
 
The germinal center is the place where B cells are activated in a T-dependent 
manner. The GC drives the generation of high affinity antibodies through repeated 
rounds of selection and somatic hypermutation of the BCR (collectively called affinity 
maturation). The heavy- and light-chain variable region of the immunoglobulin genes 
are hypermutated when centroblasts proliferate in the dark zone of the germinal 
center. The germinal center B cells undergo several rounds of cell division in the dark 
zone and accumulate mutations, then leave and experience selection in the light 
zone. The Follicular Dendritic Cells (FDCs) are coated with antigen and give a 
survival signal to high affinity centrocytes. The centrocytes must also receive signals 
generated by interaction with TH cells to survive. Some of the B cells return to the 
dark zone for additional rounds of division and mutation (Fig. 2b). Subsequent 
selection of these cells in the light zone allows the emergence of cells producing 
antibodies of higher affinity. 
 
1.1.1.4 Generation of plasma cells and memory B cells 
 
The centrocytes, which have undergone affinity maturation, differentiate into Plasma 
cells and memory B cells in the light zone. The centrocytes need proliferation 
cytokines like IL-2, IL-4 and IL-5 and differentiation cytokines like IL-2, IL-4, IL-5, IFN-
γ and TGF-β in order to perform class switching (see 1.1.1.5) and differentiate into 
Plasma cells. Plasma cells are highly specialized in the secretion of large amounts of 
antibodies and have a life span of about one month. They lack detectable 
membrane-bound immunoglobulin and synthesize high levels of secreted antibody. 
Memory B cells are latent cells that are the basis for an enhanced and more rapid 
response to repeated antigen challenge and are very similar to naive B cells, but they 
express additional immunoglobulin isotypes, including IgG, IgA, and IgE and may be 
long-lived. 
 
 

 9
1.2 Review paper 
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B cell ontogeny in the bone marrow is a complex and well regulated process 
which is essential for efficient immune responses in secondary lymphoid 
organs. B cell development is governed by multiple levels of regulation. 
Intrinsic factors regulating B cell ontogeny are constituted mainly of 
transcription factors, but also comprise intracellular molecules involved in 
signalling pathways. The cytokines and chemokines are part of the extrinsic 
factors. This review summarizes our current understanding of the intrinsic and 
extrinsic factors guiding early B cell development. Furthermore it also 
describes the role of the redox environment, which appears to play a major role 
in B cell ontogeny. 
 
 
1. Introduction 
 
B cell ontogeny is a tightly regulated process where intrinsic (transcription factors, 
signalling molecules) and extrinsic factors (cytokines, chemokines) work together to 
establish and maintain the right B cell differentiation programme. Early B cells in the 
bone marrow originate from multipotent stem cells which are able to generate all the 
precursor cells to establish the whole immune system. As these stem cells 
differentiate they gradually loose their multipotency. The hinge of B cell ontogeny is 
at the preBI cell stage, the point at which the cells become fully committed to the B 
cell lineage: at this stage the B cell transcription programme is turned on and the 
cells cannot differentiate anymore into other lineages. B cell differentiation in the 
bone marrow consists in a sequential rearrangement of the immunoglobulin (Ig) 
genes to obtain B cells expressing antibodies with many different antigen affinities 
and to select those B cells that are not autoreactive. The immunoglobulin gene 
rearrangement mechanism will not be described in this review, however a recent 
overview can be found in Cobb et al., 2006 (Cobb, Oestreich et al. 2006). The final 
output in B cell ontogeny occurs in secondary lymphoid organs such as the lymph 
nodes and the spleen, where the B cells have the potential to become activated by 
an antigen and to induce an immune response by secreting antigen-specific 
antibodies. 
The transition from a cell stage to the next depends on the activity of specific 
transcription factors which are turned on and off in a temporally regulated manner 
(Medina and Singh 2005; Pelayo, Welner et al. 2005; Hagman and Lukin 2006; 
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Figure 2: Intrinsic factors  
Key transcription factors, growth-
factor receptors, and cell-surface 
markers are shown. The green 
arrows indicate gene activation, the 
red ┬ indicate gene repression. 
Blue arrows indicate positive 
interactions. Physical interactions 
between transcription factors are 
indicated by double-pointed black 
arrows. 
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(Lowen, Scott et al. 2001) suggesting that it could negatively regulate Pax-5a in 
these cell types Figure (3c). 
 
 
 
Figure 3: Model for redox regulation of NF-κB and Pax5 
(A) Pax-5a is the full length isoform containing 10 exons. Pax5 is structured as the following 
from the N- to the C-terminus: Paired domain, octamer sequence, homeobox homology 
region, transactivation domain, and repression domain. Pax-5d lacks exons 6-10 and Pax-5e 
lacks exons 2 and 6-10. Pax-5d and -5e have a unique C-terminal sequence. All Pax-5 
proteins contain two in-frame translation start codons (ATG1 and 2). The cysteine residues 
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Distinct octamer sequences were suggested to favor or disfavor recruitment of OBF-
1. On some Ig heavy chain promoters, Oct-1 was reported to bind to the octamer site 
in a dimeric conformation (MORE) that prevents recruitment of OBF-1 to the DNA 
(Tomilin et al., 2000). On the other hand some genes such as osteopontin contain a 
permissive dimeric binding site (PORE) for Oct factors that recruits and is stabilized 
by OBF-1 (Lins et al., 2003). These octamer configurations may define a structural 
basis for OBF-1-regulated genes (Tomilin et al., 2000; Remenyi et al., 2001). The 
MORE and PORE concept is depicted in Figure 7. 
 
Figure 7: Model of an Oct-1 POU 
domain bound either to a MORE 
or a PORE sequence 
In each case, the POUs and POUH 
subdomains of one molecule are 
labeled S1 and H1 or S2 and H2. 
The flexible linker characteristic of 
the POU domain, is depicted as 
well (from Tomilin et al., 2000) 
 
1.3.2 In vivo function of OBF-1 in B cells 
 
1.3.2.1 OBF-1 expression in B cells 
 
OBF-1 expression peaks in cycling, low-density splenic B cells (including Germinal 
Center centroblasts) and can also be induced to high levels by stimulation that 
mimics T-cell help or bacterial Toll-like receptor 4 (TLR4) responses to 
lipopolysaccharide (LPS) (Qin et al., 1998; Stevens et al., 2000b; Greiner et al., 2000; 
Schubart et al., 2001). On the other hand OBF-1 is not detected in resting, high-
density splenic B cells (naïve B cells, memory B cells and GC centrocytes). In 
addition the mRNA levels of OBF-1 are high and in similar amounts in all B cell 
populations suggesting that there is a posttranslational regulation of OBF-1 protein 
expression. Indeed it was reported that the Siah RING finger proteins could interact 
with OBF-1 and mediate its degradation by the ubiquitin-proteasome pathway (Tiedt 
et al., 2001; Boehm et al., 2001). 
Figure 6: Crystal structure of a ternary 
complex containing an OBF-1 peptide, 
the POU domain of Oct1 and an octamer 
site. 
The OBF-1 peptide is shown in purple; the 
POUs domain and the POUH are represented 
in yellow and red, respectively. The OBF-1 
peptide traverses the octamer site at position 
5, as highlighted in green (from Chasman et 
al., 1999) 
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Figure 8: N-terminal sequence of p40 
Two translational start codons (CTG and ATG, respectively) are shown in bold face. A 
conserved myristoylation motif is boxed (from Yu et al., 2001). 
 
1.3.5 p40 might be cleaved into the nucleus 
 
In vitro experiments were performed to understand the machinery leading to p35 
generation. These experiments are described in the Appendix. Briefly it is proposed 
that p40 translocates into the nucleus where it may be processed into p35 potentially 
after a specific signal. p35 is probably exported into the cytoplasm by interacting with 
the nuclear exportin CRM1, then it gets myristoylated and anchors into the 
membrane. 
p35 was reported to stabilize Syk, potentially having a positive effect on preBCR 
signalling. p35 was also reported to destabilize Galectin1 (GAL1). Galectin1 is 
secreted by B cells and is a negative regulator of the CD45 phosphatase. CD45 is a 
positive regulator of the BCR signalling. Thus p35 might modulate BCR signalling by 
regulating Galectin1 level. Furthermore given that p40 is nuclear, one can postulate 
that, in addition to be a transcriptionally active protein, it represents a “storage” for 
the membrane bound p35 isoform. Together a general model can be depicted (Fig. 
9). 
 
 
Figure 9: Proposed OBF-1 
model 
The model was designed 
according to the experiments 
in the Appendix, and to the 
following papers: Yu et al., 
2001; Siegel et al., 2006; Yu 
et al., 2006. p40 might be 
cleaved into p35 in the 
nucleus. p35 then interacts 
with CRM1 and is exported 
into the cytoplasm where it is 
myristoylated. At the Plasma 
membrane p35 stabilizes Syk 
and destabilizes Galectin1 to 
modulate preBCR and BCR 
activity respectively. 
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Figure 10: Genomic sequence of the BAC 
The BAC is constituted of a 154 kb mouse genomic part containing the OBF-1 gene. 
LOC100042825, Gm684 and 1810046K07Rik are putative genes derived by automated 
computational analysis. 
 
 
1.4.3 Understanding the machinery for the p35 isoform generation 
Yu et al. showed by in vitro transcription and translation assays that the p40 isoform 
is the precursor to p35 and that is quickly processed after translation. In addition Yu 
et al. demonstrated that p35 and p34 isoforms represent ultimate translational 
products from alternative start codons (Yu et al., 2001). However the machinery for 
the generation of the myristoylated p35 isoform was not understood well. Transient 
transfection experiments suggested that p35 might have a specific function at the 
plasma membrane, as data supported the idea that p40 is cleaved into p35 in the 
nucleus and then is exported into the cytoplasm where it is myristoylated (Appendix). 
Furthermore the observation that BCR stimulation seems to be defective in OBF-1-/- 
mice (Kim et al., 1996) suggests that OBF-1 might interact with components of signal 
transduction complexes. 
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OBF1, also known as Bob.1 or OCA-B, is a B lymphocyte-specific transcription 
factor which coactivates Oct1 and Oct2 on B cell specific promoters. So far, the 
function of OBF1 has been mainly identified in late stage B cell populations. 
The central defect of OBF1 deficient mice is a severely reduced immune 
response to T cell-dependent antigens and a lack of germinal center formation 
in the spleen. Relatively little is known about a potential function of OBF1 in 
developing B cells. Here we have generated transgenic mice overexpressing 
OBF1 in B cells under the control of the immunoglobulin heavy chain promoter 
and enhancer. Surprisingly, these mice have greatly reduced numbers of 
follicular B cells in the periphery and have a compromised immune response. 
Furthermore, B cell differentiation is impaired at an early stage in the bone 
marrow: a first block is observed during B cell commitment and a second 
differentiation block is seen at the large preB2 cell stage. The cells that 
succeed to escape the block and to differentiate into mature B cells have post-
translationally downregulated the expression of transgene, indicating that 
expression of OBF1 beyond the normal level early in B cell development is 
deleterious. Transcriptome analysis identified genes deregulated in these mice 
and ID2 and ID3, known negative regulators of B cell differentiation, were found 
to be upregulated in the EPLM and preB cells of the transgenic mice. 
Furthermore, the ID2 and ID3 promoters contain octamer-like sites, which can 
bind to OBF1. These results provide evidence that tight regulation of OBF1 
expression in early B cells is essential to allow efficient B lymphocyte 
differentiation. 
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and activation (Fig. 5E). Furthermore, p53 signaling is also affected, as evidenced by 
the deregulation of the Cyclin D2 and Gadd45β genes (Fig. 5E).p53 
 
 
 
Figure 5: Microarray analysis of EPLM and large preB2 cells 
(A) Scheme for the microarray analysis. (B) Venn diagram representing the genes that are 
misregulated at least 2 fold with a p value of 0.01 in EPLM and large preB2 cells. (C) Gene 
clustering. The deregulated genes were clustered in 9 families according to their expression 
patterns. (D) Top upregulated genes from the cluster “a” with the upregulation level 
monitored in EPLM cells. (E) Gene Ontology (GO) terms in the cluster “a”.  
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Figure 6: qPCR analysis of early B cell populations 
Quantitative RT-PCR analysis of E2A, EBF1, Pax5, endogenous OBF1, ID2, ID3 and 
Syndecan1 expression in the indicated cell populations. The histograms represent the mean 
± SE of three individual mice for the EPLM and preB1 cells and two individual mice for the 
large and small preB2 cells. 
 
 
Since ID2 and ID3 genes are in gene clusters corresponding to putative OBF1 direct 
targets (Fig. 5C) and EBF1 is strongly upregulated in EPLM cells (Fig. 6) we 
searched for potential binding sites in their regulatory region, using the Transcription 
Element Search System (TESS, http://www.cbil.upenn.edu/cgi-bin/tess/tess). As 
presented in Figure 7B, the human and the mouse ID2 and 3 genes contain several 
elements with homology to the conserved octamer motif found in Ig promoters. 
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Furthermore, one of these elements is conserved in sequence and location between 
the human and mouse ID2 promoter. The human and the mouse EBF1 gene 
contains also octamer sites. The first sequence is conserved between the human and 
mouse promoters and the second element in the human promoter is a perfect 
octamer site. Abelson cell lines were used to investigate the interaction between 
OBF1 and the respective octamer sites in the ID2, ID3 and EBF1 promoters. As 
expected the Abelson cell line from BCS mice express strongly the transgene (Fig. 
7A). Chromatin immunoprecipitation was performed with Abelson cell lines from BCS, 
WT and OBF1-/- mice (Fig. 7C). Immunoprecipitation was performed with anti-OBF1 
antibody.and the chromatin regions that were amplified are depicted in red boxes in 
Fig. 7B. OBF1 interacts with ID2 and ID3 promoters in BCS and WT cells. OBF1 
interacts with EBF1 promoter only in BCS cells (Fig. 7C). One should note that EBF1 
was not clustered in Fig. 5B, because its p value (0.04) was higher than the cut off of 
0.01, although the fold change in EPLM cells was 2.2. 
 
 
 
Figure 7: ChIP 
(A) OBF1 protein level in Abelson 
cell lines. Murine OBF1, human 
OBF1 and Actin were detected by 
Western blot from pre-B cell 
cultures established from fetal 
livers by transformation with the 
Abelson (Abl) murine leukaemia 
virus. (B) Octamer-like sites in the 
mouse ID2, ID3 and EBF1 
promoter. The relative locations 
of the motifs with respect to the 
translation start codon are as 
follows: mouse ID2: -835, -2068; 
human ID2: -1048, -1067; mouse 
ID3: -2200; human ID3: -760, -
2518; mouse EBF1: -822, -933; 
human EBF1: -808, -919. (C) 
ChIP of ID2, ID3 and EBF1 
promoters. ChIP using anti-OBF1 
antibody was performed from the 
BCS, WT and OBF1-/- Abl cell 
lines. 
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Supplementary figure 
(A) FACS analysis of the spleen and peritoneal cavity. B cells were labeled with an anti-
CD19-PE antibody. The B2 cells were stained with anti-CD23-FITC. The B1a cells were 
stained with anti-CD5-FITC antibody or with anti-CD11b-FITC antibody. (B) B1, B1a, B1b 
and B2 B cell populations in the spleen and peritoneal cavity. The B2 and MZB/B1 B cells 
are CD19+CD23+ and CD19+CD23- populations respectively. The B1a and B1b B cells are 
CD19+CD5+ and CD19+CD23-CD5- populations respectively. The histograms represent the 
mean ± SD of three individual mice per genotype. 
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The B cell specific transcription factor OBF-1 comprises a nuclear and a 
cytoplasmic isoform that are generated from two active start codons. The 
cytoplasmic isoform is myristoylated at its N-terminus and localizes to 
intracellular membranes where its function is not clear yet. OBF1-/- mice have a 
severe B-cell immunodeficiency and lack germinal centers. The phenotype of 
these mice has been usually attributed to the nuclear isoform, as the function 
of OBF-1 outside the nucleus is not clear. BAC transgenic mice expressing 
each isoform were generated to investigate their capacity in rescuing the OBF-
1-/- phenotype. Indeed phenotypically the transgenic mice expressing the 
nuclear isoform looked like wild type mice indicating that it is the main player 
among the isoforms. However the in vitro hyperproliferation of ProB cells from 
OBF-1-/- mice was not rescued by the nuclear isoform. As expected, the 
comparison of microarray data from OBF-1-/- mice and BAC transgenic mice 
expressing only the nuclear isoform showed that the majority of OBF-1 
regulated genes are under the control of the nuclear OBF-1 isoform. These 
observations suggest that the cytoplasmic isoform might play a role in 
regulating proliferation of early B cells in vitro and confirm the notion that the 
nuclear OBF-1 isoform controls most of the genes misregulated in OBF-1-/- 
mice. 
 
 
Introduction 
 
OBF-1 (also known as OCA-B or Bob1) is expressed in cells of the lymphoid system 
and coactivates Oct1 and Oct2 monomers and dimers by clamping their POU 
subdomains on the conserved octamer motif (ATGCAAAT) and inducing gene 
transcription by its transactivation domain (Luo et al., 1992; Gstaiger et al., 1995; Luo 
and Roeder, 1995; Strubin et al., 1995; Sauter and Matthias, 1998; Tomilin et al., 
2000). Oct1 is expressed in almost all tissues and regulates a broad spectrum of 
target genes. On the opposite Oct2 has a restricted number of target genes and is 
mainly found in lymphoid cells. The octamer motif is essential for B cell-specific 
transcription of various genes. This motif can be found in almost all Immunoglobulin 
(Ig) promoters and enhancers (Staudt et al., 1991) and is critical for Ig gene 
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Figure 1: The BAC WT, p34 and GFP transgenic mice have the expected expression 
pattern 
(A) The BAC is constituted of a 154 kb mouse genomic part containing the OBF-1 gene. 
LOC100042825, Gm684 and 1810046K07Rik are putative genes derived by automated 
computational analysis. A schematic representation of the mutations and insertions in the 
BAC transgenic mice is depicted. The 5 exons in the OBF-1 gene are numbered. (B) 
Western blot of the splenocytes from BAC WT, BAC p34, BAC p35 and BAC GFP transgenic 
mice. (C) Western blot of purified naïve mature B cells from OBF-1+/-, BAC WT and BAC p34 
mice. Quantification of the OBF-1 level was determined with Odyssey system. OBF-1 and 
Actin were detected with Alexa 680 and 800 respectively. Shown values are the mean 
relative OBF-1 protein level ± SE of two individual mice of each genotype. 
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The B cells from BAC WT mice expressed about 2 times more OBF-1 than OBF-1+/- 
and BAC p34 mice. Therefore the BAC WT mice expressed OBF-1 like OBF-1+/+ 
mice. In the bone marrow OBF-1 was detected in none of the mouse lines, as the 
OBF-1 expression was below the detection level (data not shown). 
 
The germinal centers and the immune response are normal in the BAC p34 
mice 
 
The lack of germinal centers (GCs) and impaired immune response constitute the 
most striking phenotype of OBF-1 knock out mice (Schubart et al., 1996; Kim et al., 
1996). DNP-KLH induces a T-dependent immune response associated with the 
formation of GCs. BAC transgenic mice were immunized with DNP-KLH/Alum i.p. to 
investigate whether mice expressing only the nuclear OBF-1 isoform form GCs 
normally 10 days later. As shown in Fig. 2a, in the BAC p34 mice germinal centers 
were absolutely normal in terms of number and size. As expected, the BAC GFP 
mice were not able to generate germinal centers (Fig. 2a). 
 
 
Figure 2: p34 is sufficient to rescue the germinal centers and immune response 
(A) Germinal center immunostaining. BAC WT, BAC p34 and BAC GFP transgenic mice 
were immunized with DNP-KLH/Alum and the spleens were processed after 10 days. Spleen 
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shown). Therefore the BAC p34 mice have a normal rate of appearance of B cells in 
the periphery. 
 
 
Figure 3: p34 can rescue the splenic immature B cells and the misregulated 
Syndecan1 profile 
FACS analysis of splenocytes. The percentage of immature, mature and Syndecan1 positive 
mature B cells from total splenocytes is presented. Shown values are the mean percentage 
and absolute number, ± SE, of three individual mice. Single cell suspensions were stained 
with antibodies against the indicated markers and representative dot plots are presented. 
Biotinylated anti-CD93 in combination with streptavidin-PE-Cy5.5, anti-CD19-APC, and anti-
Syndecan1-PE antibodies were used. The immature B cells are CD19+ CD93+, the mature B 
cells are CD19+ CD93-. Syndecan1 profile from the mature B cell gate is depicted. For the 
BAC GFP mice, a GFP expression histogram of immature, mature and Syndecan1 positive 
mature B cells is illustrated. 
 
The in vitro differentiation of mature B cells from BAC p34 mice is normal 
 
As neither the immune response (Fig.2) nor the composition of the splenic B cell 
populations (Fig. 3) were impaired in the BAC p34 mice we investigated whether the 
in vitro Plasma cell differentiation was affected. It has been reported previously that in 
vitro B cell differentiation of OBF-1-/- mice is impaired upon α-CD40 and IL-4 
stimulation (Corcoran et al., 2005). Under these culture conditions the cells 
accumulated intermediate level of Syndecan1 due to a block after this differentiation 
stage. Indeed the OBF-1-/- cells are unable to initiate the genetic program for plasma 
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cell differentiation: Blimp-1/prdm1 induction fails, and bcl-6, Pax5, and AID are not 
properly repressed. 
In vitro plasma cell differentiation experiments were therefore performed to test 
whether p34 is sufficient to drive complete Plasma cell differentiation. Naïve mature B 
cells from the different transgenic mice were purified with CD43 microbeads. The 
purified cells from BAC GFP and OBF-1-/- mice maintained the Syndedan1 
overexpression phenotype observed ex vivo and all the cells from BAC GFP mice 
were positive for GFP expression (Fig. 4a). 
 
Figure 4: p34 fully rescues in vitro plasma cell differentiation  
(A) FACS analysis of naïve mature B cells. Naïve mature B cells were negatively purified 
with CD43 microbeads from total spleen. The purified cells were stained with α-Syndecan1-
PE antibody. (B) 5 days stimulation. The purified mature B cells were CFSE stained and 
cultured for 5 days with α-CD40 and IL-4. The cells were then stained with α-Syndecan1-
APC antibody. The gates represent the different levels of Syndecan1 expression in 
proliferating cells. Shown values are mean percentage ± SE, of living cells from two 
individual mice per genotype. 
 
The cells were then stained with the cell division-tracking dye carboxyfluorescein 
diacetate succinimidyl ester (CFSE) and stimulated for 5 days with α-CD40 and IL-4. 
This culture system allows monitoring the rate of proliferation and Plasma cell 
differentiation. The cells that did not divide much (high CFSE signal) displayed the 
same Syndecan1 profile as day 0 respectively: normal Syndecan1 level on cells from 
BAC WT and BAC p34 mice, and increased Syndecan1 expression on cells from 
OBF-1-/- mice. Conversely, the OBF-1-/- phenotype described by Corcoran et al. was 
clearly visible in the cells that proliferated strongly (low CFSE). Indeed the cultures 
from BAC WT and BAC p34 mice yielded significant numbers of Syndecan1high cells, 
and there was a clear deficit of Syndecan1high cells in the culture from OBF-1-/- mice 
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Figure 5: p34 can rescue the bone marrow transitional B cells 
(A) FACS analysis of bone marrow cells. Single cell suspensions of bone marrow were 
stained with anti-B220-APC and anti-IgM-PE antibodies and representative dot plots are 
presented. (B) The percentage of pro and preB, immature, transitional and recirculating 
mature B cells is presented. Shown values are the mean percentage from the lymphocyte 
gate ± SE, of three individual mice. (C) CD22 expression profile. The diagram shows Mean 
Fluorescence Intensity (MFI) of CD22 for each of the bone marrow populations. Shown 
values are average MFI ± SE of three individual mice (upper panel). Representative 
histograms for CD22 intensity are illustrated (lower panels). 
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Figure 6: p34 cannot fully rescue the in vitro proliferation of preBI cells 
(A) FACS analysis of ProB cells. Single cell suspension of bone marrow from BAC GFP mice 
was stained with anti-B220-biotin/SA-PE-Cy5.5, anti-cKit-APC, and anti-CD19-PE antibodies. 
The ProB cell population is B220/cKit positive. Within this gate the EPLM and preBI cells are 
CD19- and CD19+ respectively. (B) In vitro differentiation assay of cells from BAC transgenic 
mice. EPLM cells were cultured with IL-7 on OP9 feeder cells. The cells were stained with 
anti-CD19-PE antibody. The ex vivo EPLM cells were compared with the cells cultured under 
IL-7 condition. (C) WB of Syk and Actin expression in EPLM cultures. (D) Cell cycle assay of 
preBI cells. After 8 days culture the preBI cells were pulsed with BrdU for 45 min. and stained 
with anti-BrdU-FITC antibody and 7AAD. The G1, S and G2/M phases were calculated from 
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Figure 7: Microarray analysis of OBF-1+/+, OBF-1-/- and BAC transgenic mice 
The splenic mature B cells were FACS sorted with anti-B220-APC, anti-IgM-FITC and anti-
IgD-biotin antibodies, followed by Streptavidin-PE. The total splenic B cells were FACS 
sorted with anti-B220-APC antibody. The bone marrow mature B cells were FACS sorted 
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Figure 11: Cyclin D2 activation in B cells 
BCR-induced signal transduction pathways that positively regulate cyclin D2 
expression. In response to BCR cross-linking, the signalosome components, Btk, 
BLNK, and Vav, contribute to PLC 2 activation, which in turn leads to the generation 
of diacylgycerol (DAG) and inositol 1,4,5-trisphosphate (InsP3) and subsequent 
increase in intracellular Ca2+ and activation of PKC, both of which are necessary for 
cyclin D2 induction. PKC and Sos-Grb2-Ras activate the Raf1-MEK1/2-ERK signaling 
module; MEK1/2 is also activated by the Bam32-HPK1-MEKK1 signaling module. The 
p85  subunit of PI3K acts to link the BCR to cyclin D2 induction by way of a PKC-
Carma1-IKK-I B -NF- B signaling module. In addition, the production of 
phosphatidylinositol 3,4,5-trisphosphates by PI3K represents an important target of 
pleckstrin homology (PH) domain-containing proteins, including Btk, Vav, and PLC 2. 
CD19 is one of the main regulators of PI3K activity in B cells. The cytosolic tail of 
CD19 contains tandem YXXM motifs that are phosphorylated following BCR ligation 
and associate with the Src homology 2 domains of class I PI3K regulatory subunits. 
The individual signal transduction molecules, which have not yet been definitively 
linked to cyclin D2 induction in B cells, are highlighted in red (from  Chiles 2004). 
 
3.1.2.3.4 Foxp1 (downregulated in BCS mice): 
Foxp1 is an essential transcription factor in early B cell development as Foxp1 
defective mice have a differentiation block at the preBI to preBII transition and 
impaired V(D)J rearrangement (Hu et al., 2006). Foxp1 was shown to bind to 
the Erag enhancer and regulates Rag1 and 2 expressions. 
In our microarray Foxp1 was downreguled in large preBII cells of the BCS 
mice suggesting that it might be one cause for the differentiation block. 
However, Rag proteins were not misregulated indicating that the impaired 
differentiation, potentially mediated by the reduction of Foxp1 level, is due to 
other Foxp1 target genes. 
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3.2.3. Microarray analysis 
 
Chapter 2.2 mainly focused on the microarray data in splenic B cells. Several 
potential OBF-1 target genes could be found in this microarray. The following genes 
could be interesting, although they were not discussed in chapter 2.2. Bcl2 modifying 
factor (Bmf) plays a critical role in apoptosis and can function as a tumor suppressor. 
Interleukin-1 receptor-associated kinase 3 (IRAK3) is a negative regulator of Toll-like 
receptor signaling. B3galt7 is involved in glycosylation; interestingly B4galt1 that have 
a similar function was found to be OBF-1 dependent (Teitell, 2003). Bmf, IRAK3 and 
B3galt7 were all rescued by p34 and downregulated in mice deficient for OBF-1 (Fig. 
7c in chapt. 2.2). This microarray analysis highlighted only a small number of p35 
specific genes, and only one of these genes (BCNP1) could have a relevant 
physiological significance. 
In this section we will discuss about potential interesting genes found in microarray 
analysis of bone marrow (large preBII and mature B cells) and splenic (total splenic B 
cells) populations.  
 
 
Figure 12 : Microarray analysis in different cell populations of BAC transgenic mice 
The large preBII cells were FACS sorted with anti-B220-APC and anti-CD25-PE antibodies. 
The bone marrow mature B cells were FACS sorted with anti-B220-APC and anti-IgM-biotin 
antibodies, followed by Streptavidin-Cy5.5. The total splenic B cells were FACS sorted with 
B220-APC antibody. For every cell population three individual mice were used. The 
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Furthermore BMP-6 inhibits growth of naïve and memory B cells stimulated 
with anti-IgM or in combination with CD40L. In addition BMP-6 induces 
apoptosis of activated memory B cells (Kersten et al., 2005). 
Bmpr2 can also activate the MAP kinase-dependent pathways (Gilboa et al., 
2000; Gallea et al., 2001; von Bubnoff and Cho, 2001; Wozney, 2002; Hassel 
et al., 2003). The MAP kinase pathway associated with Bmpr2 is less 
understood than the Smad pathway. It has been suggested that TAB1 and 
TAK1, which are MAPKKK, may form a complex with BMP receptors (Gallea 
et al., 2001; von Bubnoff and Cho, 2001; Nohe et al., 2002, 2004; Wozney, 
2002; Hassel et al., 2003; Zwijsen et al., 2003). However the activation of Erk 
or p38 downstream of BMP receptors is not clear yet. 
Hassel et al. reported a cross-talk between Bmpr2 and c-kit signalling 
involving Smad proteins, Erk and p38 kinases (Hassel et al., 2006). They 
showed that Bmpr2 and c-kit form a complex and that they can cooperate 
upon BMP2 and SCF stimulation in osteoblastic differentiation. 
In our microarray experiments Bmrp2 and Smad1 were identified as p35 
specific genes and were upregulated in the total splenic B cells of BAC GFP 
mice. It is possible that p35 modulates the response of mature B cells by 
downregulating the receptor for BMP-6. Bmpr2 plays also a role in early B 
cells and was shown to cooperate with c-kit suggesting that p35 might also 
regulate the Bmpr2/c-kit mediated preBI cell differentiation. Therefore p35 
might modulate BMP signalling by downregulating Bmpr2 and Smad1. 
Furthermore MEKK1 is involved in Bmpr2 signalling upon BMP-2 stimulation 
(Hassel et al., 2006). MEKK1 is encoded by the gene Map3k1 and is part of 
the MAP kinase pathway. Gallagher et al. reported that MEKK1 is also 
required for CD40-dependent activation of the kinases Jnk and p38, germinal 
center formation, B cell proliferation and antibody production (Gallagher et al., 
2007). In our microarray experiments MEKK1 was identified as a p35 specific 
target gene and was upregulated in the splenic B cells of BAC GFP mice. This 
observation suggests that p35 might modulate the germinal center formation 
and the B cell response by downregulating MEKK1. 
Altogether it seems that p35 may be involved in Smad1 related pathways as it 
downregulates Bmrp2, Smad1 and MEKK1. The Figure 13 depicts the 
different pathways regulating the stability of Smad1, which is a key 
transcription factor in BMP signalling. 
 
Figure 13: Sequential Events in 
Smad1 Degradation. 
Activation of BMP receptor kinase 
activity leads to C-terminal 
phosphorylation of Smad1 (1). 
Activated MAPKs downstream of 
multiple inputs such as FGF or Ras can 
phosphorylate the linker domain (2), 
which provides a primed substrate for 
GSK3, which in turn is active in the 
absence of Wnt signaling (3). Smurf1 
recognizes the doubly phosphorylated 
linker domain of Smad1 and 
polyubiquitinates (Ub) it (4), targeting 
Smad1 for degradation in centrosomes 
(5) (from Verheyen et al., 2007) 
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and a COOH-terminal protein tyrosine kinase domain (PTK). Siegel et al. 
reported that Syk was hypophosphorylated in B cells from OBF-1 knock out 
mice, suggesting that OBF-1 might interact with Syk and plays a role on Syk 
phosphorylation. The activation of B lymphocytes is initiated when the B cell 
receptor for antigen (BCR) is aggregated by interactions with polyclonal 
antigens. The cytoplasmic domains of the Ig-α and Ig-β components of the 
BCR complex link the receptor to cytoplasmic protein-tyrosine kinases, the 
activation of which elicits a cascade of biochemical responses. The protein-
tyrosine kinases activated most proximal to the receptor are Syk and Lyn. In 
the resting state the SH2 domains of Syk inhibit its kinase activity presumably 
by blocking access of ATP to the kinase domain (autoinhibition). When bound 
to the BCR, Syk can assume an open conformation and phosphorylates the 
two ITAM tyrosines of Ig-α and Ig-β. The tandem SH2 domains of Syk then 
bind to the doubly phosphorylated ITAM tyrosines (ppITAM), thus fixing the 
kinase in an open and active conformation. It results a rapid phosphorylation 
of neighboring ITAM sequences, further Syk recruitment and the amplification 
of the BCR signal by a positive enzyme/product (Syk/ITAM) feedback. Fully 
activated Syk phosphorylates several cytosolic substrates, thereby leading to 
the activation of downstream signalling pathways. 
Reconstitution of the BCR complex and several of its key signalling elements 
in the evolutionary distant environment of the Drosophila S2 Schneider cell 
line (Wossning et al., 2004) was used to determine whether OBF-1 can 
modulate the function of kinases in the BCR pathway and modify the BCR 
response to antigen stimulation. However our experiments and Peter Nielsen’s 
experiments were not able to confirm this interaction in splenic B cells 
(Appendix). 
 
 
 
 
Figure 14: BCR-mediated Ras signaling pathway 
Stimulation of BCR leads to activation of proximal protein tyrosine kinases 
including Syk and Btk. Btk phosphorylates several tyrosine residues on PLC-
γ2, and subsequently activates PKCβ. PKCβ then phosphorylates RasGRP3, 
which results in the activation of Ras signaling cascade 
(web.rcai.riken.jp/en/labo/lympho/research.html). 
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The observation that p34 level associated with ID proteins expression and the 
presence of the p35 isoform are crucial for early B cell differentiation and proliferation 
respectively argue for an important role of both isoforms in early B cells. The 
hyperproliferation origin of IL-7 dependent proB cells from OBF-1-/- mice is not fully 
understood, however the 2D-DIGE assay of EPLM culture cells showed that PCNA, 
ERp5 and S100A4 were upregulated in cells from OBF-1-/- mice, which correlates 
with their hyperproliferation and probably is associated with an increased stress. 
Furthermore S100A4 is a Ca2+-binding protein which might potentially modulate the 
preBCR signalling. In fact S100A10 was downregulated in EPLM and large preB cells 
of BCS mice, which suggests that there is a negative correlation between OBF-1 and 
S100 calcium binding proteins expression. Western blot analysis of EPLM cells 
showed that Syk was downregulated in the cells lacking p35, and this defect could 
also modulate the preBCR response. 
In brief, we have generated transgenic mice overexpressing OBF-1 in B cells as well 
as mice expressing specific OBF-1 isoforms. The former showed that proper OBF-1 
expression level is crucial for early B cell development. The latter showed that the 
nuclear OBF-1 isoform plays a role during all B cell ontogeny with a main function in 
the spleen and that the cytoplasmatic isoform has a secondary function probably 
specifically in early B cells. These findings give a more detailed understanding of 
OBF-1 functions in all the B cell developmental stages. 
 
 
Figure 15: Putative model for OBF-1 
in preB cells 
In preBI cells EBF1 activates the 
transcription of OBF-1, which might 
induce Id3 expression. OBF-1 in turn 
induces EBF1 expression in a positive 
feedback loop. In large preBII CD43+ 
cells OBF-1 is upregulated potentially 
via a unknown factor (X). OBF-1 then 
might active Id2 transcription. Finally in 
large preBII CD43- cells Id2 and Id3 are 
downregulated potentially because of 
SIAH mediated proteasome 
degradation of OBF-1. 
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6 Appendix 
 
6.1 ET cloning detail 
 
6.1.1 BAC structure 
 
The BAC clone (RP24 -173L14) containing the mouse OBF-1 gene was ordered at 
the BACPAC Resource Center (BPRC) at the Children’s Hospital Oakland Research 
Institute in Oakland, California. The BAC was constructed by inserting the mouse 
genomic DNA containing the OBF-1 gene into the pTARBAC1 vector (Fig. 16) 
between the BamHI sites. The resulting BAC clone was then modified by ET cloning. 
 
 
 
 
 
Figure 16: Scheme of the plasmid that was used to construct the BAC at the BPRC. 
The structure of the cloning vector with the different restriction sites is depicted. The cloning 
vector confers Chloramphenicol resistance (CM). The genomic DNA was inserted between 
the BamHI restriction sites. 
6.1.2 ET cloning scheme 
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The following ET cloning procedure was adapted from the Counter-Selection BAC 
modification kit protocol from GeneBridges, Dresden, Germany. The name ET 
cloning comes from the RecE/RecT (or Redα/Redβ in our protocol) recombinases 
which are used to recombine homologous sequences. Briefly in a first step the rpsL-
neo cassette is introduced in the location of interest. After selection against the 
selectable marker neo with Kanamycin the correct recombinants can be verified. In a 
second modification step the rpsL-neo cassette is replaced by a PCR generated non-
selectable fragment. By selecting against the counter-selectable marker rpsL with 
Streptomycin, only bacteria which have undergone successful substitution by the 
non-selectable fragment will grow (Fig. 17). 
 
 
 
 
Figure 17 : ET cloning scheme 
The procedure is described in the text. The plasmid pBADαβγ (Ampr) expresses the ET 
recombinase. hm = homology, Cm = Chloramphenicol resistance gene, non-sm = non-
selectable marker 
 
 
The plasmid pBADαβγ(Ampr), which encodes the recombinases and is L-arabinose 
inducible, was a gift from Prof. Busslinger and the plasmid pRpsLneo was ordered at 
GeneBridges to generate PCR fragments containing the rpsL and neo cassette. 
6.1.3 ET cloning protocol 
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6.2 In vitro and in vivo studies 
 
The section 6.2 gives an overview of some experiments that were performed during 
the PhD thesis to have a better understanding of the mechanism responsible for the 
different intracellular localizations of the OBF-1 isoforms (6.2.1 and 6.2.2), of some 
potentially interesting genes related to the BAC transgenic mice (6.2.3), of the 2D-
DIGE assay from EPLM cells (6.2.4), of the Syk behaviour in OBF-1-/- mice (6.2.5) 
and of potential OBF-1 target genes in early B cells (6.2.6). 
 
6.2.1 Distinct subcellular localizations of OBF-1 isoforms in transfected 
cells 
 
Yu et al. was the first to report the existence of a cytoplasmatic OBF-1 isoform (Yu et 
al., 2001). Transfection experiments with GFP fusion constructs were performed to 
get a better understanding of the OBF-1 isoforms localizations. The p40 and p34 
isoforms were found to be nuclear and the p35 isoform was cytoplasmatic. 
Furthermore p35 formed nuclear speckles after Leptomycin B (LMB) treatment, which 
is a specific inhibitor of CRM1 (nuclear exportin) (Fig. 18). This observation 
suggested that p35 had the potency to be exported out of the nucleus in a CRM1 
dependent manner. The nuclear speckles are structures that contain high 
concentrations of splicing snRNPs and other splicing-related proteins (Handwerger 
and Gall, 2006). Nuclear speckles are thought to serve as a reservoir for factors that 
participate in the cotranscriptional splicing of mRNA at the chromosomes. 
Furthermore it is thought to be a way-station for components that accompany mRNA 
to the nuclear pore and/or cytoplasm (Handwerger and Gall, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p40.GFP 
p35.GFP 
p34.GFP 
p35(G->A).GFP p35.GFP + LMB 
Figure 18: GFP assay 
The p40, p35 and p34 OBF-1 isoforms were fused to GFP on 
the C-terminus and transfected in COS-7 cells. The nuclei 
were stained with DAPI. Cells transfected with p35.GFP were 
also treated with LMB. The N-terminal Glycine of p35 was 
also mutated into Alanine.
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Figure 20: Nuclear exportin machinery 
CRM1 is the main nuclear exportin protein and LMB inhibits its activity by antagonizing the 
binding of Cargo proteins and preventing Ran-GTP interaction (from Yashiroda et al., 2003). 
 
Coimmunoprecipitation assays were performed to investigate whether OBF-1 would 
interact with CRM1. 293T cells were transfected with GAL4.CRM1 and OBF1.GFP 
constructs. The HA tagged GAL4.CRM1 (GAL4 fused to CRM1) was 
immunoprecipitated by α-HA antibody and the OBF1-GFP fusion proteins were 
detected with α-GFP antibody by WB (Fig. 21). As a result p40.GFP, p35.GFP and 
p34.GFP to a lesser extend were coimmunoprecipitated with GAL4.CRM1 indicating 
that indeed the OBF-1 isoforms can bind to CRM1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: CoIP OBF1/CRM1 
293T cells were transfected with OBF1.GFP and GAL4.CRM1 constructs. GAL4.CRM1 
was immunoprecipitated with α-HA Ab. The coimmunoprecipitated OBF1.GFP were 
detected with α-GFP Ab. 
The Mammalian two-hybrid assay is a method to investigate interactions between 
two proteins. A reporter plasmid bearing the luciferase gene with a promoter 
Cytoplasm Nucleus
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containing 5 GAL4 binding sites is transfected with the Renilla reference plasmid. A 
schematic representation of the Mammalian two-hybrid assay is illustrated in Figure 
22. 
 
 
Figure 22: Schematic representation of the Mammalian Two-Hybrid System. 
The pG5LucVector contains five GAL4 binding sites upstream of a minimal TATA box, which 
in turn, is upstream of the firefly luciferase gene. In negative controls, the background level of 
luciferase is measured in the presence of GAL4 (from the pBIND Vector) and VP16 (from the 
pACT Vector). Interaction between the two test proteins, as GAL4-X and VP16-Y fusion 
constructs, results in an increase in luciferase expression over the negative controls 
(www.promega.com/pagide/chap11.htm). 
 
CRM1 and OBF-1 were fused to GAL4 and VP16 respectively. VP16 induces the 
luciferase transcription when the protein partners interact (Fig. 23). Indeed CRM1 
could bind to OBF-1 and the interaction was better with p35 than with p40. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Mammalian two-hybrid assay 
293T cells were transfected with luciferase reporter plasmid containg GAL4 binding sites, 
with a pRL control plasmid, with CRM1 fused to GAL4 and with OBF-1 fused to VP16. The 
values correspond of the mean ± SE of 2 independent experiments. 
6.2.3 qPCR analysis of BAC transgenic mice 
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Smad1, Map3k1 and KLF12 were identified as p35 specific genes in the microarray 
experiment in total splenic B cells from BAC transgenic mice (Fig. 12). To investigate 
their expression pattern in stimulated B cells, mature B cells were CFSE labelled and 
stimulated with α-CD40 and IL-4. The cells expressing different level of Syndecan1 
were sorted by FACS after 5 days. QPCR analysis revealed that the cells from BAC 
p34 mice could not downregulate properly Smad1 and Map3k1. On the other hand 
the overexpression of KLF12 in the cells from OBF-1-/- mice was rescued by p34 (Fig. 
24). 
 
 
Figure 24: qPCR of in vitro stimulated mature B cells 
(A) Mature B cells were CFSE stained and cultured for 5 days with α-CD40 and IL-4. The 
cells were then stained with α-Syndecan1-APC antibody. The red gates represent the 
populations that were sorted for RNA analysis. (B) QPCR analysis of the populations 
expressing different levels of Syndecan1. The values represent mean ± SE of two 
independent mice for BAC WT and BAC p34 genotypes and one OBF-1-/- mouse. 
6.2.4 2D-DIGE assay 
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The deletion of OBF-1 results in hyperproliferation of ProB cells in vitro (see chapter 
2.2). To have a better understanding of molecular origin of hyperproliferation, 2D-
DIGE assay was performed with EPLM cell cutlures from BAC WT and OBF-1-/- mice 
(Fig. 25). In fact the cells from OBF-1-/- mice overexpress PCNA, PDIA6 and S100A4, 
which might explain the hyperproliferation of these cells. These results are discussed 
in the section 3.2.4. 
 
6.2.5 Collaboration with Peter Nielsen: putative involvement of the 
protein tyrosine kinase Syk 
 
Roeder reported that OBF-1 might interact with Syk in splenic B cells. Therefore we 
started a collaboration with Dr. Peter Nielsen at the Max Planck Institute in Fribourg 
(Germany) to try confirming his results. However the experiments did not confirm an 
interaction between Syk and OBF-1 in mature B cells. 
 
Drosophila S2 cells were transfected with Syk fused to RFP and OBF-1 isoforms 
fused to GFP (Fig. 26). In the cells cotransfected with Syk and p35, blobs on the cell 
periphery where Syk and p35 colocalize appeared. The origin of these blobs was not 
understood. 
Figure 25: DIGE assay 
DIGE assay was 
performed on EPLM 
cell cultures of BAC WT 
and OBF-1-/- mice. The 
proteins upregulated in 
cells from OBF-1-/- mice 
are in red. 
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An artificial BCR can be reconstituted in these S2 cells by transfecting its 
components (Wossning and Reth, 2004). Syk is the main BCR kinase and 
phosphorylates SLP-65 upon activation. When the BCR is reconstituted in the S2 
cells, Syk is activated and phosphorylates SLP-65. Peter Nielsen performed 
transfection experiments in S2 cells to investigate Syk response and stability upon 
OBF-1 cotransfection (Fig. 27). When OBF-1 was cotransfected, Syk appeared to be 
hypophosphorylated. Furthermore Syk level might be decreased in presence of p35 
isoform. 
 
 
Figure 26 : Cotransfection 
experiments in S2 cells 
S2 cells were transfected with 
Syk-RFP and OBF1-GFP. 
Figure 27: Syk response in 
transfected S2 cells 
S2 cells were transfected as the 
scheme. Tyrosine phosphoryation 
(4G10), Syk, SLP-65 and OBF-1 
level were detected by WB. 
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Although the S2 cell transfection allowed investigating individually the components of 
the BCR signalling, it is an artificial method. Therefore primary mature B cells from 
two independent OBF-1-/- mice strains (those from our lab and those from Nielsen et 
al.) were analysed. Figure 28 shows the result from a Western blot of stimulated and 
unstimulated splenic B cells. Stimulating the B cells with anti-IgM for 15 hours 
induced Syk expression both in WT and KO mice, to roughly the same extent. It also 
looked like Syk expression in B cells from OBF-1-deficient mice was at least as 
strong as in B cells from heterozygote mice. This does not correlate with the results 
published by Roeder's group in Cell where they showed that Syk expression seemed 
to decrease after stimulation and was significantly lower in B cells from OBF-1-
deficient mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: In vitro B cell stimulation 
Splenic mature B cells were stimulated for 15 hours with anti-IgM. Bob1 and obf1 are mice 
from Fribourg and Basel respectively. WB of Syk was performed with the cell extracts. 
 
 
Coimmunoprecipitation experiments were also performed in transfected 293T cells, 
however only the first experiment seemed to show an interaction between Syk and 
OBF-1. All the subsequent attempts failed to show this interaction (data not shown). 
Furthermore mammalian two-hybrid assays with GAL4.Syk and OBF1.VP16 did not 
allow to evidence any interaction (data not shown). Therefore neither Peter Nielsen 
nor our lab could reproduce Roeder’s results in mature B cells and confirm a direct 
interaction between Syk and OBF-1, although these two proteins colocalized in 
transfected S2 cells. 
 
 
 165
6.2.6 Gadd45β and Cyclin D2 are potential OBF-1 direct target genes 
 
Microarray data from EPLM and large preBII cells of BCS mice suggested that 
Gadd45β and Cyclin D2 were direct target genes of p34 (2.1). Indeed octamer sites 
were discovered on their promoters. Chromatin immunoprecipitation (ChIP) of OBF-1 
in WT Abelson cells was performed to investigate the OBF-1 binding potential on 
these octamer sites (Fig. 29). The ChIP procedure is described in Material and 
Methods. In fact OBF-1 binding was detected on the respective promoters suggesting 
that OBF-1 might be involved in Gadd45β and Cyclin D2 expression in early B cells. 
 
 
 
 
 
 
 
 
 
 
Figure 29: Chromatin Immunoprecipitation (ChIP) of Gadd45β and Cyclin D2 octamer 
sites 
ChIP was performed from WT Abl cells. α-OBF1 Ab and control rabbit IgG were used. The 
regions that were amplified by PCR are depicted by a red rectangle. 
 
 


